Pfizer Inc. (PFE)

Last Price: 37.23 (2020-11-27)

Company Description

Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and consumer healthcare products. Pfizer's Animal Health business unit discovers, develops and sells products for the prevention and treatment of diseases in livestock and companion animals. It sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, veterinarians, livestock producers, and grocery and convenience stores. Pfizer Inc. is headquartered in New York.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $51.75B
Net Income (Most Recent Fiscal Year) $16.27B
PE Ratio (Current Year Earnings Estimate) 12.68
PE Ratio (Trailing 12 Months) 12.82
PEG Ratio (Long Term Growth Estimate) 3.01
Price to Sales Ratio (Trailing 12 Months) 4.17
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 3.10
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) 8.89
Pre-Tax Margin (Trailing 12 Months) 17.48%
Net Margin (Trailing 12 Months) 17.85%
Return on Equity (Trailing 12 Months) 24.88%
Return on Assets (Trailing 12 Months) 9.32%
Current Ratio (Most Recent Fiscal Quarter) 1.40
Quick Ratio (Most Recent Fiscal Quarter) 1.13
Debt to Common Equity (Most Recent Fiscal Quarter) 0.76
Inventory Turnover (Trailing 12 Months) 1.13
Book Value per Share (Most Recent Fiscal Quarter) $11.78
Earnings per Share (Most Recent Fiscal Quarter) $0.72
Earnings per Share (Most Recent Fiscal Year) $2.95
Diluted Earnings per Share (Trailing 12 Months) $1.55
Stock
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers - General
Common Shares Outstanding 5.56B
Free Float 5.55B
Market Capitalization $203.05B
Average Volume (Last 20 Days) 50.82M
Beta (Past 60 Months) 0.65
Percentage Held By Insiders (Latest Annual Proxy Report) 0.08%
Percentage Held By Institutions (Latest 13F Reports) 60.30%
Annual Dividend (Based on Last Quarter) $1.52
Dividend Yield (Based on Last Quarter) 4.16%